Bottom line
How much do XLV and TMED overlap?
47% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 40.4% of XLV's assets and 45.5% of TMED's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings XLV and TMED have in common
| Holding | % of XLV | % of TMED | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.51% | 16.71% | 16.51% |
| UnitedHealth Group Inc | 6.57% | 6.52% | 6.52% |
| Thermo Fisher Scientific Inc | 3.24% | 4.11% | 3.24% |
| Gilead Sciences Inc | 2.73% | 4.44% | 2.73% |
| Intuitive Surgical Inc | 2.45% | 2.43% | 2.43% |
| Pfizer Inc | 2.39% | 1.91% | 1.91% |
| Danaher Corp | 2.09% | 2.96% | 2.09% |
| Stryker Corp | 1.89% | 2.22% | 1.89% |
| McKesson Corp | 1.58% | 1.46% | 1.46% |
| Cencora Inc | 0.96% | 2.75% | 0.96% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XLV
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Abbott Laboratories — 2.75%
- CVS Health Corp — 2.30%
- Vertex Pharmaceuticals Inc — 2.19%
- Bristol-Myers Squibb Co — 2.05%
- Medtronic PLC — 1.75%
- Elevance Health Inc — 1.46%
- Cigna Group/The — 1.27%
- Boston Scientific Corp — 1.10%
- Regeneron Pharmaceuticals Inc — 1.08%
- HCA Healthcare Inc — 1.05%
- Cardinal Health Inc — 0.97%
Only in TMED
- Agilent Technologies Inc — 2.61%
- Alnylam Pharmaceuticals Inc — 2.60%
- Insulet Corp — 2.38%
- Dyne Therapeutics Inc — 2.03%
- Elanco Animal Health Inc — 1.91%
- Cytokinetics Inc — 1.69%
- Waters Corp — 1.68%
- West Pharmaceutical Services — 1.65%
- Ascendis Pharma A/s — 1.60%
- Biogen Inc — 1.55%
- Dexcom Inc — 1.46%
- Immunome Inc — 1.38%
- Biontech Se-adr — 1.29%
- Humana Inc — 1.24%
- Denali Therapeutics Inc — 1.22%
Asset mix
| Asset type | XLV | TMED |
|---|---|---|
| Stocks | 99.7% | 99.3% |
| Cash & short-term funds | 0.3% | 0.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | XLV | TMED |
|---|---|---|
| US | 97.9% | 93.3% |
| IE | 2.1% | — |
| DK | — | 1.6% |
| DE | — | 1.6% |
| KY | — | 1.1% |
| NL | — | 0.9% |
| CH | — | 0.5% |
| CA | — | 0.3% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do XLV and TMED overlap?
What stocks do XLV and TMED have in common?
Should I own both XLV and TMED?
Which holds more stocks, XLV or TMED?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.